Investigational Drug Details
| Drug ID: | D460 |
| Drug Name: | HU6 |
| Synonyms: | -- |
| Type: | Biological drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | Controlled Metabolic Accelerators |
| Clinical Trial Progress: | Phase 2 completed (NCT04874233) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0288 | NCT04874233 | Phase 2 | Completed | No Results Available | April 19, 2021 | February 2, 2022 | Details |
| L0300 | NCT04709913 | Phase 1 | Completed | No Results Available | January 4, 2021 | August 16, 2021 | Details |
| L0303 | NCT04463017 | Phase 1 | Completed | No Results Available | August 12, 2020 | May 4, 2021 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|